Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Cancer Letters
|
March 28, 2006
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
Roberta Pang, Ronnie T P Poon
Cellular and Molecular Life Sciences : CMLS
|
February 2, 2013
Biomarkers for predicting future metastasis of human gastrointestinal tumors
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang
Cancer Letters
|
October 22, 2005
Molecular pathways in hepatocellular carcinoma
Roberta Pang, Eric Tse, Ronnie T P Poon
Expert Opinion on Pharmacotherapy
|
August 17, 2010
Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib
Thomas Yau, Roberta Pang, Pierre Chan, et al.
Cancer
|
July 15, 2010
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma
Thomas Yau, Pierre Chan, Roberta Pang, et al.
Annals of Surgical Oncology
|
April 5, 2007
High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies
Ronnie T P Poon, Cecilia Lau, Roberta Pang, et al.
Expert Opinion on Investigational Drugs
|
April 9, 2010
Chemoprophylaxis in colorectal cancer: current concepts and a practical algorithm for use
Victoria P Y Tan, Pierre Chan, Ivan F N Hung, et al.
World Journal of Gastroenterology
|
November 17, 2012
Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study
Victoria P Y Tan, Tin K Cheung, Wai M Wong, et al.
The American Journal of Pathology
|
January 22, 2013
PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin
Chi-Wai Cheng, Ariel K M Chow, Roberta Pang, et al.
The Oncologist
|
September 3, 2011
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib
Thomas Yau, T J Yao, Pierre Chan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Cancer Letters
|
March 28, 2006
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
Roberta Pang, Ronnie T P Poon
Cellular and Molecular Life Sciences : CMLS
|
February 2, 2013
Biomarkers for predicting future metastasis of human gastrointestinal tumors
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang
Cancer Letters
|
October 22, 2005
Molecular pathways in hepatocellular carcinoma
Roberta Pang, Eric Tse, Ronnie T P Poon
Expert Opinion on Pharmacotherapy
|
August 17, 2010
Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib
Thomas Yau, Roberta Pang, Pierre Chan, et al.
Cancer
|
July 15, 2010
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma
Thomas Yau, Pierre Chan, Roberta Pang, et al.
Annals of Surgical Oncology
|
April 5, 2007
High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies
Ronnie T P Poon, Cecilia Lau, Roberta Pang, et al.
Expert Opinion on Investigational Drugs
|
April 9, 2010
Chemoprophylaxis in colorectal cancer: current concepts and a practical algorithm for use
Victoria P Y Tan, Pierre Chan, Ivan F N Hung, et al.
World Journal of Gastroenterology
|
November 17, 2012
Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study
Victoria P Y Tan, Tin K Cheung, Wai M Wong, et al.
The American Journal of Pathology
|
January 22, 2013
PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin
Chi-Wai Cheng, Ariel K M Chow, Roberta Pang, et al.
The Oncologist
|
September 3, 2011
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib
Thomas Yau, T J Yao, Pierre Chan, et al.
Page
of 4